Cancer BiologybioRxivPreprint
RET activation controlled by MAB21L4-CacyBP interaction drives squamous cell carcinoma
A. Srivastava, C. Tommasi, D. Sessions…·C. S. Lee
This study identifies RET activation driven by MAB21L4-CacyBP interaction as a driver of squamous cell carcinoma and shows RET inhibition as a potential therapeutic strategy.
DOI 10.1101/2022.01.19.476979